Orelabrutinib, the Glossary
Orelabrutinib is a drug for the treatment of cancer.[1]
Table of Contents
4 relations: Bruton's tyrosine kinase, Chronic lymphocytic leukemia, Enzyme inhibitor, Mantle cell lymphoma.
- Acrylamides
- Antineoplastic and immunomodulating drugs
- Diphenyl ethers
- Kinase inhibitors
Bruton's tyrosine kinase
Bruton's tyrosine kinase (abbreviated Btk or BTK), also known as tyrosine-protein kinase BTK, is a tyrosine kinase that is encoded by the BTK gene in humans.
See Orelabrutinib and Bruton's tyrosine kinase
Chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).
See Orelabrutinib and Chronic lymphocytic leukemia
Enzyme inhibitor
An enzyme inhibitor is a molecule that binds to an enzyme and blocks its activity.
See Orelabrutinib and Enzyme inhibitor
Mantle cell lymphoma
Mantle cell lymphoma (MCL) is a type of non-Hodgkin's lymphoma, comprising about 6% of cases.
See Orelabrutinib and Mantle cell lymphoma
See also
Acrylamides
- Acrylamide
- Acrylfentanyl
- Anthramycin
- Aumolertinib
- BMF-219
- Belinostat
- Canertinib
- Clocinnamox
- Furylfuramide
- Ibrutinib
- Methacrylamide
- Monocrotophos
- N,N'-Diallyl-L-tartardiamide
- N,N'-Methylenebisacrylamide
- N-(2-Hydroxypropyl) methacrylamide
- Olmutinib
- Opnurasib
- Orelabrutinib
- Osimertinib
- Poly(N-isopropylacrylamide)
- Polyacrylamide
- Poseltinib
- Remibrutinib
- Rociletinib
- Sparsomycin
Antineoplastic and immunomodulating drugs
- ATC code L
- Aldoxorubicin
- Amikhelline
- Antineoplastic drugs
- Aumolertinib
- Belvarafenib
- CPI-0610
- Custirsen
- Daratumumab
- Daratumumab/hyaluronidase
- Fuzuloparib
- Gardiquimod
- Gedunin
- Gumarontinib
- Linrodostat
- Methotrexate
- Opaganib
- Orelabrutinib
- Palytoxin
- Peginterferon beta-1a
- Rigosertib
- Surufatinib
- Utidelone
- Valemetostat
- Vebreltinib
- Vemurafenib
Diphenyl ethers
- 4,4'-Oxydianiline
- Abafungin
- Aplaviroc
- BAY 38-7271
- BAY 59-3074
- Barceloneic acid A
- Belzutifan
- Berbamine
- Bumetanide
- Cavicularin
- Chloroxuron
- Clefamide
- DAA-1097
- DAA-1106
- Decabromodiphenyl ether
- Dextrothyroxine
- Dibenzofuran
- Diphenyl ether
- ELQ-300
- Elsulfavirine
- Etofenprox
- Fenoprofen
- Fomesafen
- Funicin
- Lactofen
- Liothyronine
- Orelabrutinib
- Oxyfluorfen
- Pentabromodiphenyl ether
- Polybrominated diphenyl ethers
- Ponazuril
- Sanguisorbic acid
- Silafluofen
- Triiodothyronine
- Valoneic acid
- Zanubrutinib
Kinase inhibitors
- BX-912
- CHIR99021
- Defactinib
- Enitociclib
- GW-788,388
- Gumarontinib
- LY-2109761
- Mobocertinib
- Orelabrutinib
- Pimicotinib
- Protein kinase inhibitors
- RepSox
- Surufatinib
- Tovorafenib
- Vebreltinib
- Zanubrutinib
- Zanzalintinib